Home
Log in
Home
World
Politics
Business
Tech
Health
Science
Climate
Education
/
/
Back
AbbVie’s zumilokibart meets phase 2 atopic dermatitis endpoint
All
Left
Center
Right
Blindspot
1 sources
Investing.com
1h ago
Center
AbbVie’s zumilokibart meets phase 2 atopic dermatitis endpoint
AbbVie’s zumilokibart meets phase 2 atopic dermatitis endpoint
Original